Legal Representation
Attorney
Montra Yazdani
USPTO Deadlines
Next Deadline
51 days remaining
Final Refusal E-Mailed
Due Date
March 03, 2026
Extension Available
Until June 03, 2026
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 3, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Dec 3, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Dec 3, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 31, 2025 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Oct 31, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Oct 23, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 23, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 23, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 23, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 23, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 23, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 23, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 23, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 16, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 12, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 12, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
adhesive patches for medical purposes, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing an active ingredient for dermal delivery for Anti-Inflammation, Chronic and Acute Pain, Neural Diseases such as Dementia or Alzheimer's, Hormonal Application (hormone replacement therapy), Smoking Cessation, Cardiac and Blood Diseases (blood pressure and angina), Anti-Nausea (motion sickness), Chronic Respiratory Diseases and Rhinitis, Overactive Bladder, or Depression and Mental Health; vitamin and supplement patches, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing one or more vitamins or supplements for dermal delivery for Vitamin Deficiencies, General Wellbeing, Boosting Energy, and Recovery and Support; transdermal patches that facilitate the delivery of CBD, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing a hemp-derived THC-free CBD preparation for dermal delivery; patches containing pharmaceutical preparations, namely adhesive patches including a biodegradable electrospun nanofibrous mat containing the pharmaceutical preparation for dermal delivery for Anti-Inflammation, Chronic and Acute Pain, Neural Diseases such as Dementia or Alzheimer's, Hormonal Application (hormone replacement therapy), Smoking Cessation, Cardiac and Blood Diseases (blood pressure and angina), Anti-Nausea (motion sickness), Chronic Respiratory Diseases and Rhinitis, Overactive Bladder, or Depression and Mental Health; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing for use with cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
Classification
International Classes
005